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ABSTRACT
The structure of a C11 peptidase PmC11 from
the gut bacterium, Parabacteroides merdae, has
recently been determined, enabling the
identification and characterization of a C11
orthologue, PNT1, in the parasitic protozoon
Trypanosoma brucei. A phylogenetic analysis
identified PmC11 orthologues in bacteria,
archaea, Chromerids, Coccidia and
Kinetoplastida, the latter being the most
divergent. A primary sequence alignment of
PNT1 with clostripain and PmC11 revealed the
position of the characteristic His-Cys catalytic
dyad (H99 and C136), and an Asp (D134) in the
potential S1 binding site. Immunofluorescence
and cryo-electron microscopy revealed that
PNT1 localizes to the kinetoplast, an organelle
containing the parasite’s mitochondrial genome
(kDNA), with an accumulation of the protein at
or near the antipodal sites. Depletion of PNT1 by
RNAi in the T. brucei bloodstream form was
lethal both in in vitro culture and in vivo in mice
and the induced population accumulated cells
lacking a kinetoplast. In contrast, overexpression
of PNT1 led to cells having mislocated
kinetoplasts. RNAi depletion of PNT1 in a
kDNA independent cell line resulted in
kinetoplast loss but was viable, indicating that
PNT1 is required exclusively for kinetoplast
maintenance. Expression of a recoded wild type
PNT1 allele, but not of an active site mutant
restored parasite viability after induction in vitro
and in vivo confirming that the peptidase activity
of PNT1 is essential for parasite survival. These
data provide evidence that PNT1 is a cysteine
peptidase that is required exclusively for
maintenance of the trypanosome kinetoplast.
INTRODUCTION
Trypanosoma brucei is a kinetoplastid protozoan
parasite and the causative agent of human
African trypanosomiasis (sleeping sickness) and
nagana in cattle. Sleeping sickness causes
widespread human morbidity and death in sub-
Saharan Africa. Nagana leads to cattle mortality,
lower meat and milk production and lower
calving rate. The parasite has a complex life
cycle spanning both the tsetse fly and the
mammalian host. The metacyclic trypomastigote
is transmitted to the mammalian host by the bite
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these parasites transform into bloodstream form
(BSF) trypomastigotes that divide and multiply
in blood and lymph, and which is followed by
invasion of the parasites to other organs and the
central nervous system. The sleep-wake cycle
gets disrupted and if the disease is left untreated,
the infected individual enters coma and
eventually dies (1). Approximately 60 million
people are at risk of being infected worldwide
with this disease (WHO fact sheet May 2015).
Currently no vaccines are available and the
drugs in use are becoming ineffective and are
toxic (2,3). It is therefore imperative that new
drug targets are identified against the protozoan
parasite.
Cysteine peptidases of parasitic protozoa are
associated with important biological processes
such as, invasion of the host cells (in case of
intracellular parasites) and subsequent
pathogenesis (4,5). Clan CD is comprised of
peptidase families that have a protein fold
similar to the caspase family (C14). Clan CD is
exemplified by several important cysteine
peptidases such as GPI8 (family C13), a
component of the GPI:proteintransamidase
complex (6); metacaspase (family C14B) (7,8);
separase (family C50) (9) and a relatively less
characterized family C11 (clostripain) (10). In T.
brucei the GPI:proteintransamidase is required
for anchoring proteins to the plasma membrane.
Among these proteins the most prominent is
VSG (variant surface glycoprotein), which forms
a monolayer on the parasites surface and
functions in the evasion of the host’s immune
system (6). T. brucei has five metacaspases,
including MCA4, which is a pseudopeptidase
and virulence factor (11) and MCA2, which is a
calcium-dependent enzyme associated with
RAB11 positive endosomes and does not require
processing for activation (12,13). Another T.
brucei cysteine peptidase, separase, functions in
segregation of mini-chromosomes and proper
mitotic assembly (14).
Recently, the first crystal structure of a family
C11 peptidase, PmC11, was determined from the
gut bacterium Parabacteroides merdae (15).
This structure facilitated the identification of an
important T. brucei protein, PNT1 (Puf Nine
Target 1) as a C11 orthologue and a potential
cysteine peptidase. The PNT1 transcript was
previously described, in the insect procyclic
form of the parasite, as the target of the RNA
binding protein PUF9 (16), with PNT1
localizing to the kinetoplast, a unique organelle
containing the organism’s mitochondrial DNA.
The kinetoplast DNA (kDNA) of T. brucei is
composed of a few dozen maxicircles (23kb) and
several thousand minicircles (~1kb) (17). The
maxicircles encode essential mitochondrial
proteins including the respiratory chain complex
subunits. The minicircles encode guide-RNAs
that function in editing the RNA encoded by the
maxicircles. The division of the mitochondrial
DNA is coordinated with cytokinesis (18) and
the presence of essential genes on the kinetoplast
makes it imperative for each of the T. brucei
progeny cells to inherit a kinetoplast (19).
Related species, T. equiperdum and T. evansi, do
not have a fully functional kinetoplast and are,
therefore, known as dyskinetoplastic (20). RNAi
studies on kinetoplast regulatory genes have
shown that loss of the kinetoplast in T. brucei is
lethal; hence, the organelle is considered an
important drug target (19,21). Our functional
analysis suggests that PNT1 is a peptidase that
plays an essential role in the maintenance of the
kinetoplast, and that a catalytically active PNT1
is required for the survival of T. brucei. This
work also demonstrates that depletion of PNT1
leads to the generation of an akinetoplastic cell
line, whereas overexpression leads to formation
of mislocated kinetoplasts thus, inhibitors of
PNT1 could be of interest for drug discovery
programmes.
EXPERIMENTAL PROCEDURES
Phylogenetic analysis—The peptidase C11
hidden Markov model (HMM) profile (ACC
PF03415.9) was obtained from Pfam
(www.pfam.org). The C11 peptidases are
members of clan CD (www.merops.org), a group
characterised by a doublet [H(G|A)] and triplet
[D(A|S)C] motif accounting for the catalytic
histidine/cysteine dyad (22). The UniProtKB
FASTA set (04/29/2015) was downloaded from
the UniProt site (www.uniprot.org). This
sequence set was searched for peptides
containing domains consistent with the model
(conformant proteins) by use of the HMM search
program of HMMER3 (http://hmmer.org/) using
default parameters. The hits (full sequence E-
value <0.0001) were filtered as follows:
Sequences from prokaryotic and archaeal species
were excluded; eukaryotic alignments were
examined and only those with at least a
minimum alignment to the cysteine containing
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for the identified eukaryotic sequences were
subsequently retrieved from UniprotKB; and a
representative sample of bacterial and archaeal
C11 peptidase sequences were obtained from the
MEROPS database (www.merops.org) and
added to the sequence set.
The meta-method for assembling multiple
sequence alignments was performed on the
sequence set using the M-Coffee (23) mode of
T-Coffee (24). The output alignment (color
coded for alignment quality) was examined
visually to determine the domain containing the
doublet [H(G|A)] and triplet [D(A|S)C]. The
alignment was trimmed to this domain, and an
HMM profile generated (C11_euk), using the
HMMER3 program hmmbuild. This HMM
profile was used to search proteome sets of a
variety of eukaryotic genomes for C11_euk
conformant sequences. The domain sequences
were extracted, the sequence for metacaspase
TbMCA2 (Trypanosoma brucei Tb927.6.940,
MEROPS family C14, also in clan CD) was
added as an outgroup and a multiple sequence
alignment was generated as above. Low quality
(<4) and low occupancy (<30%) sites were
removed from the alignment and a neighbour-
joining tree generated from the refined
alignment (SplitsTree4 (25)),
www.splitstree.org).
Trypanosome cell culture—T. brucei 2T1
bloodstream form (BSF) cells were maintained in
HMI-9 medium supplemented with 10% FBS
(low TET, GIBCO), 100 U mL-1 penicillin 100
µg mL-1 streptomycin. The parasites were
transfected as described (26) and clones were
obtained by limiting dilution. Appropriate
concentrations of antibiotics were used for the
selection and maintenance of the parasites: 2 µg
mL-1 puromycin, 2.5 µg mL-1 phleomycin, 5 µg
mL-1 hygromycin B and 10 µg mL-1 blasticidin
(all from InvivoGen). RNAi was induced using 1
µg mL-1 tetracycline. Cells were grown in 24-
well plates in triplicate for growth curve
experiments.
Generation of the RNAi, recoded and
Myc-tagged PNT1 constructs—a PNT1 RNAi
construct (pTL232) was generated using
pGL2084, a gateway compatible version of
pRPaSLi(27,28). The oligonucleotides used for the
generation of sense and antisense PNT1 inserts
for pTL232 were
(OL4052:GGGGACAAGTTTGTACAAAAAA
GCAGGCTCGTCAGGACATGCTTGAAGA,
and
OL4053:GGGGACCACTTTGTACAAGAAAG
CTGGGTTTTGCAATTCTTTCTGTGCG).
pTL232 was digested with AscI and the stem
loop cassette was transfected in bloodstream
form T. brucei 2T1. A recoded gene (encoding
mRNA that is refractory to RNAi) of PNT1 was
designed in CLC genomics workbench (CLCbio)
using the codon usage table of T. brucei and
subsequently synthesized by GeneArt (Thermo
Fisher Scientific). The recoded PNT1 gene was
cloned in frame with a C-terminal HA tag in
pGL2243 (29), which integrates the gene of
interest at the tubulin locus for constitutive
expression. Site-directed mutagenesis was carried
out on the recoded PNT1 to generate an active
site recoded mutant protein PNT1HAC136A. The
mutations were carried out using the Quick-
change Site-directed Mutagenesis kit (Stratagene)
as per the manufacturer’s protocol. The
identifiers of PNT1 HA recoded and the mutated
constructs are pGL2278 and pGL2320
respectively. The oligonucleotides used to
generate the mutated recoded PNT1 were
(OL4280:CGATGGTTTTTGATAGTAGTTTCA
TGGCGAGCCTGG and OL4281:
CCAGGCTCGCCATGAAACTACTATCAAAA
ACCATCG). PNT1 was cloned in frame in a
tetracycline inducible 6X C-Myc tag vector
(pGL2220) (27) for generating a PNT1Myc cell
line.
Transfection of the parasites—1 × 107 log
phase BSF cells were suspended in 100 μL of 
ice-cold Amaxa Human T-Cell solution (Amaxa,
Koeln, Germany) and transfection carried out
according to the manufacturer’s protocol. Briefly,
10 μg of linearized DNA plasmid was added to 
the cells and transfected with the Amaxa Human
Nucleofector II, using program X-001. The cells
were transferred to pre-warmed HMI 11 medium
and plated out in 24-well plates at 1:20 and 1:40
dilutions. The selection antibiotic was added after
6 h of transfection and cells incubated at 37 °C.
Transfectants were selected after a week. F1FO-
ATPase subunit γL262P mutants (20) were 
generated in the PNT1 RNAi cell line using gene
replacement constructs (Matt Gould and Achim
Schnaufer, unpublished). Briefly, two rounds of
transfections were carried out to replace both the
endogenous subunit γ alleles with γL262P mutant 
alleles. The cell lines were tested for kDNA
independence by treating with 10 nM ethidium
bromide for four passages, which resulted in
generation of viable akinetoplastic cells.
Analysis of trypanosome growth after
induction of RNAi—The PNT1 RNAi cell lines
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in 24 well plates (HMI 11 hygromycin-
phleomycin media) in the presence and absence
of tetracycline (1 µg ml-1). The cell numbers
were counted using a haemocytometer every 24 h
and cell seeded at 1 × 105 cells for the subsequent
time point. Infections in mice were carried out by
initially inoculating a donor mouse with 1 × 105
parasites and monitoring blood parasitemia over
72 h. Four experimental mice were infected with
4 × 104 parasites harvested from the donor
mouse. Doxycycline was added to the drinking
water of two of the mice on the day of
inoculation. Parasitaemia in the blood of the mice
was calculated daily using a haemocytometer
after drawing the blood by tail venepuncture and
diluting the blood in 0.83% ammonium chloride.
Cumulative growth curves were plotted for the in
vivo and in vitro cell counts using Prism6
(GraphPad Software). The experiments were
done in triplicate for in vitro and in duplicate for
in vivo experiments.
Real time PCR—2 × 105 BSF cells were
grown for 24 h in the presence and absence of
tetracycline, harvested and RNA was prepared
using the RNeasy kit (Qiagen). First strand
cDNA was prepared using 4 µg of RNA for each
sample (Invitrogen Superscript: First strand
synthesis kit). The cDNA was treated with RNase
H (Invitrogen) to degrade the template RNA.
PCR was performed using SYBR green PCR
master mix (Applied Biosystems) and GPI8 was
used as an endogenous control. Oligonucleotides
OL4119: CACTTGGGTGGGCTCTCTTTC and
OL4120:CAGCGGCTTCGACAATGG were
used for amplifying PNT1, and
OL2272:CGAAGCGCATTTGGATAGC and
OL2273:AGCGCGTGATGACAGTGAAG to
amplify GPI8.The qPCR was run and analysed
on a 7300 Real time PCR system (Applied
Biosystems).
SDS-PAGE and Western blotting of T.
brucei cell lysates—1 × 107 BSF parasites were
lysed in sample buffer (NuPAGE sample buffer)
and analysed on a 4-12% NuPAGE Novex Bis-
Tris gel using MES buffer. Subsequently, the
samples were electro blotted on nitrocellulose
membrane (GE healthcare) and probed with the
respective antibodies. The PNT1HA cell line was
probed with anti-HA antibody (1:4000, Roche).
The PNT1Myc cell line was probed with anti-
Myc antibody (1:2000, Millipore). Anti-EF1-
alpha antibody (1:5000, Millipore) was used for
the loading controls.
Immunofluorescence—DAPI staining
was carried out using 106 cells from exponential
phase cultures. The cells were washed with vPBS
(22,28), added to a 12-well glass slide (Thermo
Fisher) pre-coated in poly-L lysine (0.1% w/v in
H2O, Sigma), and allowed to adhere for 4 min.
Cells were fixed with of 4% para-formaldehyde
(PFA) for 5 min. The wells were washed twice
with PBS (pH 7.4) and excess PFA was
quenched with 100 mM glycine for 10 min. The
cells were permeabilized with 0.1% Triton X-100
for 10 min. The wells were washed three times
with PBS and overlaid with a drop of SlowFade
Gold Antifade Reagent with DAPI (Invitrogen).
Coverslips were added and the slides were kept at
4°C until required. Staining of PNT1HA was
performed using 1 x 107 cells from an
exponential phase culture. The cells were
resuspended in 200 µl PBS followed by addition
of 300 µL of 4% PFA to fix overnight at 4°C.
The cells were washed with PBS and
resuspended in 100 mM glycine for 15 min. The
cells were then centrifuged at 600 g for 10 min
and resuspended in 0.1% Triton X-100 (Sigma)
for 5 min. Cells were washed twice with PBS and
incubated on ice for 1 h in 1% BSA (in PBS).
The cells were centrifuged for 600 g for 10 min
and incubated with anti-HA antibody (1:200, Rat
monoclonal, Roche) for 1 h on ice. After washing
with 0.1% BSA (PBS) cells were resuspended in
anti-Rat Alexa-488 (1:2000, Molecular Probes)
and incubated in the dark on ice for 1 h. The cells
were washed with 0.1% BSA (PBS) before 0.5 µl
DAPI (100 µg/ml stock) was added to the cells
and incubated for 5 min. The cells were washed
once with 0.1% BSA (PBS) and once with PBS.
The final cell pellet was resuspended in final
volume of PBS (30 – 50 µL) and stored at 4°C
until ready to image. The staining of the
PNT1Myc cell line was also carried out as
described above using an anti Myc antibody
conjugated to Alexa Fluor 488 (Millipore) at
1:500 dilution. Stained cells were spread on a
slide and overlaid with a square coverslip. The
images were acquired on a DeltaVision Core
microscope using excitation wavelength of 405-
489 nm and images were analysed and processed
in Adobe Photoshop and FIJI.
Transmission electron microscopy—
Cells were washed in PBS, fixed with 2.5%
glutaraldehyde and 4% paraformaldehyde in 0.1
M sodium cacodylate buffer (pH 7.2), and post-
fixed with 1% osmium tetroxide and 2.5%
potassium ferrocyanide in 0.1 M sodium
cacodylate buffer (pH 7.3) for 45 min in the dark.
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uranyl acetate, dehydrated in a series of acetone
solutions (30, 50, 70, 90 and 100%) and finally
embedded in Epon resin. Collected ultrathin
sections were stained with lead citrate prior to
observation in a Tecnai T20 transmission
electron microscope (FEI, Netherlands). All
images were analysed and processed in Adobe
Photoshop and FIJI (30). Acquired images were
processed and the intensity plot profile acquired
for kinetoplast density analysis. Statistical
analyses were performed using Prism6, with one-
way ANOVA analysis. Immuno-gold labelling
of cells was done by fixing cells overnight in 4%
paraformaldehyde in phosphate buffer, and
dehydrating in ascending ethanol solutions. The
material was progressively infiltrated with LR
White resin, and polymerization was carried out
in gelatine capsules under ultraviolet light.
Formvar-coated nickel grids with ultrathin
sections were incubated with blocking solution
(3% BSA, 0.02% Tween 20, in phosphate buffer,
pH 8) for 1 h. The grids were then incubated with
the primary antibody anti-HA (1:200 rat
monoclonal, Roche) diluted in blocking buffer
for 1 h followed by several washes in blocking
buffer. The grids were then incubated with
protein A conjugated to immunogold (Aurion,
Netherlands) for 1 h. After several washes with
blocking buffer and phosphate buffer, the grids
were stained with uranyl acetate and lead citrate
prior to observation in a Tecnai T20 transmission
electron microscope (FEI, Netherlands).
RESULTS
Phylogeny of the C11 cysteine peptidase
family—To determine the phylogenetic
distribution of C11 proteins, the UniProt
database was queried with a bespoke C11
Hidden Markov Model (HMM) domain profile.
This analysis identified clostripain-like proteins
in a wide range of bacterial and archaeal species
and in a limited range of eukaryotic species,
which could be divided into distinct clades
(branches) (Fig 1A). One clade, containing a
subset of species from Chromerida, Coccidia
and Chlorophyta, is monophyletic with the
archaeal and bacterial species, as exemplified by
P. merdae PmC11 (15) and Clostridium
histolyticum clostripain, and suggests a lateral
gene transfer event from a non-eukaryotic
species to a plastid-containing organism
ancestral to these phyla (31). The sparse
distribution of the C11 domain is indicative of
frequent loss from genomes in successive rounds
of evolution, as there is no evidence of C11
proteins among species of Babesia or
Plasmodium, whereas C11 proteins are found in
other apicomplexan genera including
Toxoplasma, Eimeria and Neospora. A second
clade (kin) is present in kinetoplastids and is
atypical in comparison to other eukaryotic
species and bacterial/archaeal domains. The C11
domain is found in T. brucei (PNT1),
Leishmania and Bodo saltans, but not in
Phytomonas, Leptomonas or Paratrypanosoma,
indicating secondary loss of the PNT1 gene in
kinetoplastid groups.
Active PNT1 is essential for
Trypanosoma brucei viability—PNT1 is the
ortholog of PmC11 in T. brucei (Fig. 1A). A
primary sequence alignment of PmC11,
clostripain and PNT1 (Fig. 1B) led to the
identification of the conserved His-Cys catalytic
dyad (H99 and C136, respectively). PmC11 is
somewhat shorter than the other two proteins but
large sections of all three overlay well, covering
most of the PmC11 residues with particularly
good alignment around the active site. This
suggests that the secondary structural elements
identified in PmC11 will form the core structural
elements of clostripain and PNT1.
Attempts to obtain soluble recombinant
PNT1, for testing protease activity in vitro, were
unsuccessful. However, it was possible to
investigate peptidase activity and its importance
in parasite survival indirectly. Initially, a PNT1
RNAi line was generated in the bloodstream-
form (BSF) of T. brucei, where induction by
tetracycline resulted in loss of cell viability in
the in vitro culture (Fig. 2A). PNT1 was also
observed to be essential in vivo with doxycycline
induction leading to loss of detectable
parasitaemia in mice after 96 h (Fig. 2B).
To test whether catalytically active
PNT1 is required for the survival of the
parasites, a recoded version of PNT1, containing
a C-terminal HA tag (PNT1HA, which is
refractory to RNAi) was constitutively expressed
in the PNT1 RNAi line. Expression of the
PNT1HA recoded protein compensated for the
loss of endogenous PNT1 and restored viability
of tetracycline induced parasites both in vitro
culture (Fig. 2C) and in vivo (Fig. 2D). A cell
line in which the recoded PNT1HA had the
predicted active site cysteine mutated to serine
PNT1HAC136S was not viable after induction in
vitro (Fig. 2E) and in vivo (Fig. 2F). Quantitative
RT-PCR confirmed the depletion of PNT1
mRNA in each of the cell lines (insets of Fig’s.
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that PNT1HAC136S was expressed at a similar
level to PNT1HA (Fig. 3A). Another interesting
observation from the Western blots was the
absence of processed fragments of recoded
PNT1HA suggesting that PNT1 might not
require processing for activity. This is in contrast
to PmC11, which requires intramolecular
processing for full activation (15). This
observation is further supported by the primary
sequence alignment of PNT1 with PmC11 and
clostripain, where the cleavage site Lys (K147)
in PmC11 aligns with a reported cleavage site
Arg (R190) in clostripain (32), whereas in PNT1
there is an Ala at the equivalent position (Fig.
1B). Additionally, phylogenetic analysis (Fig.
1A) shows that trypanosomatid C11 orthologues
are quite divergent from bacterial and archaea
C11 family members. These results suggest that
PNT1 is different from PmC11 in terms of
activation and that the peptidase activity of
PNT1 is essential for viability of T .brucei.
PNT1 localizes on the kinetoplast—
PNT1 localizes to the kinetoplast in BSF
parasites and was enriched either within or near
the antipodal sites, which are protein assemblies
located on opposite sides of the kDNA disc
involved in minicircle replication (33,34). This
localization was more prominent in dividing
kinetoplasts (Fig. 3B). Immunogold-labelling of
the PNT1HA cell line confirmed that PNT1HA
is located on the kinetoplast (Fig. 3C (i, ii)). The
status of the kinetoplast in PNT1-depleted cells
was investigated using TEM, which showed a
lower electron density of the kinetoplast in
RNAi-induced cells compared to uninduced cells
(Fig’s. 3(iii, iv). This indicates that PNT1
depletion results in a reduction of material
within the kinetoplast. It has been demonstrated
that RNAi-mediated depletion of proteins
closely associated with the kinetoplast, can cause
the loss of kDNA (35,36). In order to observe
the effects of downregulating PNT1 on number
of nuclei and kinetoplasts, the PNT1 RNAi line
was stained with DAPI at different time points
after induction. Depletion of PNT1 by RNAi
resulted in increased number of cells lacking a
kinetoplast (akinetoplastic, 1N0K) after 2 days
(Fig. 3D). The number of 1N0K cells increased
from 16% on day 2 to 46% on day 4, after RNAi
induction. This increase in akinetoplastic cells
suggests that PNT1 is involved in the
maintenance of the kinetoplast in T. brucei.
Interestingly, inducible overexpression of a
Myc-tagged PNT1 (PNT1Myc) leads to
formation of an additional kinetoplast anterior to
the nucleus, a phenotype similar to that observed
in the procyclic form of T. brucei (16). In
addition, 36% of the induced PNT1Myc cell line
had a mislocated kinetoplast after 48h of
induction (Fig. 4A,B). PNT1 was also localized
on these incorrectly positioned kinetoplasts (Fig.
4B (lower panel)).
Overexpression of PNT1 led to an increase of
1N2K cells from 12% to 39% after 24 h of
induction, compared to 12% observed in
uninduced cells (Fig. 4C). However, the number
of 1N2K cells in the induced culture decreased
to 14% and 8% at 48 h and 72 h time points,
respectively. The T. brucei cell cycle is a well-
co-ordinated event in which the kinetoplast is
placed posterior to the nucleus during
cytokinesis. In cells overexpressing PNT1,
mislocated kinetoplasts found anterior to the
nucleus were observed in cells at all stages of the
cell cycle. The decrease in the number of
kinetoplasts might be due to continuous
cytokinesis of cells having mislocated
kinetoplasts. PNT1 overexpression by
tetracycline induction also leads to loss of cell
viability in BSF T. brucei (Fig. 4D). Importantly,
cell death is observed when PNT1 is either
downregulated or overexpressed, indicating that
an optimal amount of PNT1 peptidase activity is
essential for viability of the parasite.
PNT1 is required exclusively for
maintenance of the kinetoplast—A kinetoplast-
independent PNT1 RNAi cell line was generated
to investigate whether PNT1 is required
exclusively for kinetoplast maintenance or
whether it has other essential mitochondrial
functions. It has recently been demonstrated that
an L262P mutation in the F1γ subunit of the F1-
F0 ATPase complex allows BSF T. brucei to
survive loss of the kinetoplast (20). The PNT1
RNAi line was modified to replace both of the
wild-type γ alleles with L262P mutant alleles. 
The PNT1 RNAi was then induced with
tetracycline. No growth defect was observed
after induction (Fig.5A, left panel) despite
greater than 90% depletion of the PNT1
transcript (Fig. 5A, right panel). Additionally,
depletion of PNT1 resulted in a 100%
akinetoplastic cell population after 4 days of
induction. Thus, PNT1 is redundant in the
absence of a requirement for the kinetoplast for
cell viability (Fig. 5B). Taken together, these
data indicate that PNT1 is exclusively required
for kinetoplast maintenance and becomes
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requirement for the organelle.
DISCUSSION
The structure of a bacterial C11 protein (PmC11)
(15) allowed the catalytic dyad of the PNT1
orthologue to be identified and probed. Despite
being larger than PmC11, a basic primary
sequence alignment suggests that the secondary
structural elements identified in PmC11 will
form the core structural elements of PNT1 (Fig
1B). Our data and others (16) indicate that PNT1
is present at the ends of the kinetoplast, which
could be the antipodal sites where newly
replicated minicircles reattach to the network for
repairing discontinuities during replication (such
as gap filling and ligation) (37,38). Several
proteins have been identified at the antipodal
sites of the kinetoplast including helicases
(33,39), a minicircle origin binding protein p38
(40), DNA polymerase β (41), and a DNA 
primase PRI1 (42), among others. Depletion of
p38 (40), PIF8 (33) and PRI1 (42) also result in
loss of kDNA, a similar phenotype to PNT1
depletion; however, there is no evidence to
suggest that these proteins require proteolytic
processing whereas it is the peptidase activity of
PNT1 that is essential. To date, only one other
protease, HslVU (43) has been found to regulate
kDNA maintenance in T. brucei. Unlike PNT1,
downregulation of HslVU leads to over-
replication of minicircles and formation of large
kDNA networks. Moreover, HslVU localizes
throughout the mitochondrion, suggesting that
HslVU could have other roles in the organelle,
whereas PNT1 is required exclusively for kDNA
maintenance. The appearance of an additional
kinetoplast in an abnormal position observed
after PNT1 overexpression is reminiscent of the
‘ancillary’ kinetoplasts reported after ablation of,
DNA polymerase IC (44) or the acyl carrier
protein (45), and of those observed in candidate
gametes of T. brucei (46). Phylogenetic analysis
of PNT1 orthologues suggests that kinetoplastid
PNT1 genes are very divergent from orthologues
of other organisms. The sequence alignment of
PNT1 with PmC11 revealed the presence of
conserved structural elements, but also showed
novel elements indicating that they have evolved
to perform some kinetoplastid-specific function.
Not all kinetoplastids have PNT1; Phytomonas
and Leptomonas appear to lack a PmC11
orthologue, which might indicate that there are
alternative regulatory mechanisms for kDNA
replication in these organisms. It is also
interesting to note that T. evansi and T.
equiperdum have a PNT1 gene, even though
these organisms are dyskinetoplastic (47). It is
possible that PNT1 is required for maintenance
of minicircles in these organisms, although there
are no data currently to support this hypothesis.
Further work on the identification of PNT1
substrates would provide exciting new insights
into the mechanism of kinetoplast replication
and segregation in T. brucei as well as guiding
inhibitor and possibly drug discovery.
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FIGURE LEGENDS
FIGURE 1.Phylogenetic analysis of the clan CD C11 peptidase family. A, Unrooted neighbour
joining tree of the C11 family from bacteria and archaeal species (Bact/Arch), Coccidia (Cocc),
Chromerida (Chro), Chlorophyta (Chl) and Kinetoplastids (Kin; A. Trypanosoma, B.
Leishmania/Endotrypanum/Crithidia, C. Bodonida). Clostripain (+)Uniprot ID: P09870,
PmC11(*)Uniprot ID: A7A9N3, and PNT1 (#)Uniprot ID:Q385B4 are marked. Key: 1; K2PE90,
Trypanosoma cruzi. 2; A0A061IWY5 T. rangeli. 3; F9W8X5 T. congolense. 4; Tb927.11.6550 T.
brucei. 5; G0UBL1 T. vivax. 6; Q4QH06 Leishmania major. 7; AOFS01001278.1 2 2 2134
Endotrypanum monterogeii. 8; CfaC1 13 0800 Crithidia fasciculata. 9; BS39455 Bodo saltans. 10;
EQ973215 Bacteroides fragilis. 11; GL883824 Paraprevotella xylaniphila. 12; AHHG01000029
Elizabethkingia anophelis. 13; P09870 Clostridium histolyticum. 14; ADLW01000010
Dysgonomonas mossii. 15; AE010299 Methanosarcina acetivorans. 16; SNAP00000001341
Eimeria tenella. 17; B6ABJ5|Cryptosporidium muris. 18; MER037012 Cryptosporidium parvum.
19; Cvel 15101 Chromera velia. 20; A0A086LCT5 Toxoplasma gondii. 21 V4ZRY6 Toxoplasma
gondii. 22; F0VJH3 Neospora caninum. 23; U6G6U0 Eimeria praecox. 24; MER494436 Vitrella
brassicaformis. 25; D8TW66 Volvox carteri. 26; A8I9P1 Chlamydomonas reinhardtii. 27;
A0A0D2MVH2 Monoraphidium neglectum. 28; NC 018015 Thermococcus sp. CL1. 29;
ABYK01000024 Arthrospira maxima. 30; DS990529 Aciduliprofundum boonei. 31; A7A9N3
Parabacteroides merdae. 32; AJ437303) Trypanosoma brucei MCA2 (outgroup). B, Primary
amino acid sequence alignment of PmC11 (from Parabacteroides merdae), PNT1 (from T. brucei)
and clostripain (from Clostridium histolyticum) with identical residues highlighted in grey shading.
The assigned secondary structure from the crystal structure of PmC11 (15) is mapped onto its
sequence with the position of the PmC11 catalytic dyad and auto-catalytic cleavage site (K147)
highlighted by a red star and a red triangle, respectively. Connecting loops are colored gray/black,
the main β-sheet is in orange, with other strands in olive, α- helices in blue and the nonapeptide 
linker of clostripain underlined in red. Sequences around the catalytic site of clostripain, PmC11,
and PNT1 are aligned where identical residues are highlighted in grey.
FIGURE 2. Growth of PNT1 RNAi cell lines in vitro and in vivo. A and B, PNT1 RNAi cell line.
C and D PNT1 RNAi cell line expressing recoded PNT1HA. E and F, PNT1 RNAi cell line
expressing recoded PNT1HAC136S. A, C and E representative growth curves show cumulative cell
counts after induction of RNAi with tetracycline in vitro (mean of three independent experiments)
(inset: PNT1 mRNA depletion monitored by qRT-PCR). B, D and F, 4 mice were inoculated
intraperitoneally with 4 x 104 parasites and RNAi was induced with doxycycline in 2 mice at the
time of inoculation. Uninduced mice were culled when the parasitemia levels were higher than108
cells/ml. The parasitemia in blood samples were plotted over time.
FIGURE 3. Phenotype analysis of PNT1 RNAi, PNT1HA and PNT1Myc cell lines. A, Expression
of recoded PNT1HA in the PNT1 RNAi cell line. Lysates of PNT1 RNAi cells expressing recoded
PNT1HA (lanes 1 and 2) or recoded PNT1HAC136S (lanes 3 and 4) before (lanes 1 and 3) and after
(lanes 2 and 4) tetracycline induction were immunoblotted and probed with anti-HA antibody.
EF1α was used as loading control. B, Immunofluorescence of PNT1HA expressed in tetracycline
induced PNT1 RNAi cell line (lower panel) shows localization within or near antipodal sites.
Uninduced PNT1 RNAi cell lines (upper panel) were used as a control. The cells were stained with
anti-HA antibody (green) and DAPI (blue). A stained, nearly duplicated kinetoplast (yellow box) is
shown in magnified view. Scale bar; 5µm. C, (i, ii) Immuno gold labelling of PNT1HA cell line
using anti-HA antibody after 72 h of RNAi induction. Scale bar; 100 nm. (iii, iv) Electron
micrographs of PNT1 RNAi uninduced (iii) and 72 h tetracycline induced (iv) cells (scale bar; 150
nm). D, PNT1 RNAi cells induced with tetracycline (Tet+) were stained with DAPI and the
number of nuclei (N) and kinetoplasts (K) per cell was counted (in 200 cells) at the indicated time
points and plotted as a percentage of the total. Each histogram represent mean ±SD (n=3).
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FIGURE 4. Overexpression of PNT1 A, Upper panel, Western blot showing expression of
PNT1Myc using anti-Myc antibody at different time points after tetracycline induction (lanes 2,3
and 4 represent induced samples after 24, 48 and 72 h respectively). A 24 h uninduced PNT1Myc
sample in lane 1 served as negative control. EF1α was used as the loading control. Lower panel, 
Percentage of cells having anterior kinetoplasts after tetracycline induction at different time points
(quantitation from 200 cells, histogram represents mean ± SD (n=3)). B, Representative images
showing the DAPI-stained, PNT1Myc-tagged cell line before (top panel) and after (middle panel)
induction with tetracycline for 24 h. Bottom panel, Staining of PNT1Myc cell line with anti-Myc
antibody conjugated to Alexa fluor 488 (green). Scale bar; 5µm. C, Counts of DAPI stained
kinetoplast (K) and nuclei (N) of the PNT1Myc cell line showing a higher percentage of 1N2K
cells at 24 h after induction. The number of 1N2K cells fall after 48 and 72 h (n=3, mean±SD). D,
cumulative growth curve of PNT1Myc cell line showing reduced cell viability after PNT1
overexpression.
FIGURE 5. PNT1 is exclusively required for kinetoplast function. A, Left panel, cumulative
growth curve of PNT1 γL262P RNAi line over time ± tetracycline (n=3). Right panel, the mRNA 
levels of PNT1 transcript were evaluated in the induced and uninduced γL262P PNT1 RNAi cell
line using qRT-PCR. Each histogram represents the mean ± SD (n=3). B, Loss of kinetoplast in
γL262P PNT1 RNAi cell line after addition of tetracycline to downregulate PNT1. The cells were
grown for 120 h ± tetracycline and stained with DAPI. Scale bar; 5µm.
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